ALES MEDEK,BEILI ZHANG,BRIAN LUISI,MARIUSZ KRAWIEC
申请号：
BR112012009584
公开号：
BR112012009584A2
申请日:
2010.10.21
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
The present invention relates to substantially crystalline and solid state forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide (Form A-HCl, Form B, Form B-HCl, or any combination of these forms), pharmaceutical compositions thereof, and methods of treatment therewith.
